See more : DMCC Speciality Chemicals Limited (DMCC.NS) Income Statement Analysis – Financial Results
Complete financial analysis of Hin Sang Group (International) Holding Co. Ltd. (6893.HK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Hin Sang Group (International) Holding Co. Ltd., a leading company in the Household & Personal Products industry within the Consumer Defensive sector.
- Jiangsu Nanfang Medical Co., Ltd. (603880.SS) Income Statement Analysis – Financial Results
- Yogi Infra Projects Limited (YOGISUNG.BO) Income Statement Analysis – Financial Results
- Jammin Java Corp. (JAMN) Income Statement Analysis – Financial Results
- Jiangsu Shemar Electric Co.,Ltd (603530.SS) Income Statement Analysis – Financial Results
- Harte Gold Corp. (HRT.TO) Income Statement Analysis – Financial Results
Hin Sang Group (International) Holding Co. Ltd. (6893.HK)
Industry: Household & Personal Products
Sector: Consumer Defensive
Website: https://www.hinsanggroup.com
About Hin Sang Group (International) Holding Co. Ltd.
Hin Sang Group (International) Holding Co. Ltd., together with its subsidiaries, primarily engages in the manufacture, marketing, and sale of healthcare products primarily targeting at children in Hong Kong and Mainland China. The company operates through four segments: Product Development, Brand Development and Management, Trading of Goods, and Healthcare. The Product Development segment develops and sells personal care products, household products, and health supplements under the Hin Sang, Tai Wo Tong, Cheers Smart, Care Plus, Shuang Long, and King's Antiseptic brand names. The Brand Development and Management segment engages in marketing, selling and distribution, logistics, and delivery services of personal care products under the Pahmi, Enear, Vcnic, Zici, and Sunew brand names; and manages and develops brands for its brand proprietors. The Trading of Goods segment engages in the distribution and sale of skin care products, personal care products, and household products purchased from various authorized dealers, independent traders, manufacturers, parallel importers, and suppliers. The Healthcare segment provides Chinese medical healthcare related services for mothers and children; develops mother and child related health products; and hospital, medical center, and related services. It is also involved in the trading of skin care, personal care, and slimming products; and property holding business. The company sells its products in Hong Kong, as well as sells through a network of distributors in the People's Republic of China and Macau. It also sells its products online. The company was founded in 1996 and is headquartered in Tsim Sha Tsui, Hong Kong. Hin Sang Group (International) Holding Co. Ltd. is a subsidiary of Genwealth Group Holding Company Limited.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 92.62M | 81.46M | 120.55M | 119.44M | 176.21M | 183.98M | 188.55M | 201.82M | 227.46M | 214.96M | 253.17M | 235.11M |
| Cost of Revenue | 35.21M | 42.62M | 51.47M | 50.65M | 57.82M | 56.59M | 57.38M | 68.57M | 89.09M | 92.30M | 110.83M | 136.70M |
| Gross Profit | 57.41M | 38.84M | 69.08M | 68.79M | 118.39M | 127.38M | 131.18M | 133.24M | 138.37M | 122.66M | 142.34M | 98.41M |
| Gross Profit Ratio | 61.98% | 47.67% | 57.30% | 57.60% | 67.19% | 69.24% | 69.57% | 66.02% | 60.83% | 57.06% | 56.22% | 41.86% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.77M |
| General & Administrative | 67.01M | 70.31M | 78.07M | 87.01M | 92.66M | 98.60M | 87.08M | 77.68M | 65.47M | 65.34M | 49.30M | 43.89M |
| Selling & Marketing | 12.53M | 5.35M | 6.84M | 10.96M | 21.98M | 27.20M | 37.85M | 41.01M | 47.82M | 45.13M | 34.53M | 31.52M |
| SG&A | 79.54M | 75.66M | 84.91M | 97.97M | 114.63M | 125.80M | 124.94M | 118.69M | 113.30M | 110.47M | 83.83M | 75.41M |
| Other Expenses | 0.00 | 2.45M | 3.14M | 1.15M | 1.26M | 580.00K | 815.00K | 199.00K | 309.00K | 299.00K | 50.00K | 0.00 |
| Operating Expenses | 79.54M | 75.66M | 79.98M | 95.25M | 114.63M | 125.80M | 124.94M | 118.40M | 112.76M | 109.37M | 83.25M | 77.34M |
| Cost & Expenses | 114.75M | 118.28M | 131.45M | 145.90M | 172.45M | 182.39M | 182.31M | 186.97M | 201.85M | 201.67M | 194.08M | 214.05M |
| Interest Income | 80.00K | 757.00K | 120.00K | 97.00K | 201.00K | 1.58M | 3.58M | 4.66M | 4.91M | 2.17M | 1.32M | 0.00 |
| Interest Expense | 16.30M | 14.06M | 12.85M | 11.04M | 5.80M | 1.82M | 0.00 | 8.00K | 0.00 | 0.00 | 1.24M | 1.29M |
| Depreciation & Amortization | 16.92M | 18.11M | 20.39M | 21.28M | 20.17M | 11.36M | 10.59M | 8.36M | 5.09M | 2.67M | 1.77M | 2.02M |
| EBITDA | -3.58M | -17.05M | 21.82M | -4.35M | -2.66M | 5.67M | 16.83M | 22.92M | 30.41M | 25.27M | 61.66M | 25.03M |
| EBITDA Ratio | -3.86% | -22.28% | 9.67% | -3.27% | 14.25% | 9.37% | 15.41% | 10.55% | 11.70% | 8.42% | 24.73% | 10.64% |
| Operating Income | -22.13M | -36.82M | -15.83M | -29.18M | 3.76M | 1.59M | 18.47M | 19.70M | 30.82M | 15.76M | 60.46M | 23.00M |
| Operating Income Ratio | -23.90% | -45.20% | -13.13% | -24.43% | 2.13% | 0.86% | 9.80% | 9.76% | 13.55% | 7.33% | 23.88% | 9.78% |
| Total Other Income/Expenses | -14.66M | -12.40M | 4.42M | -7.49M | -32.39M | -9.10M | -5.18M | -1.54M | 1.66M | -7.15M | 1.29M | -3.22M |
| Income Before Tax | -36.80M | -49.22M | -11.42M | -36.67M | -28.63M | -7.51M | 1.06M | 13.02M | 26.98M | 15.45M | 61.18M | 19.78M |
| Income Before Tax Ratio | -39.73% | -60.43% | -9.47% | -30.70% | -16.25% | -4.08% | 0.56% | 6.45% | 11.86% | 7.19% | 24.16% | 8.41% |
| Income Tax Expense | -395.00K | -55.00K | 1.69M | 174.00K | 3.62M | 4.11M | 8.28M | 4.71M | 5.77M | 4.40M | 11.47M | 4.40M |
| Net Income | -36.71M | -49.49M | -11.91M | -31.95M | -19.79M | 4.67M | 530.00K | 9.80M | 21.21M | 11.05M | 49.70M | 15.38M |
| Net Income Ratio | -39.63% | -60.75% | -9.88% | -26.75% | -11.23% | 2.54% | 0.28% | 4.85% | 9.33% | 5.14% | 19.63% | 6.54% |
| EPS | -0.03 | -0.05 | -0.01 | -0.03 | -0.02 | 0.00 | 0.00 | 0.01 | 0.03 | 0.02 | 0.08 | 0.03 |
| EPS Diluted | -0.03 | -0.05 | -0.01 | -0.03 | -0.02 | 0.00 | 0.00 | 0.01 | 0.03 | 0.02 | 0.08 | 0.03 |
| Weighted Avg Shares Out | 1.09B | 1.09B | 1.09B | 1.09B | 1.09B | 1.09B | 1.09B | 1.02B | 800.13M | 691.51M | 600.00M | 600.01M |
| Weighted Avg Shares Out (Dil) | 1.09B | 1.09B | 1.09B | 1.09B | 1.09B | 1.10B | 1.09B | 1.03B | 803.61M | 691.51M | 600.00M | 600.00M |
Source: https://incomestatements.info
Category: Stock Reports